11. “We believe that Syndros will be an important new treatment option for patients suffering from the devastating effects of chemotherapy induced nausea and vomiting, as well as those fighting anorexia associated with weight loss in AIDS.” – Insys Therapeutics Inc (NASDAQ:INSY) CEO and President, Dr. John N. Kapoor.
Follow Insys Therapeutics Inc. (NASDAQ:INSY)
Follow Insys Therapeutics Inc. (NASDAQ:INSY)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
